Osteoarthritis (OA) is a debilitating degenerative disease affecting multiple joint tissues,
including cartilage, bone, synovium, and adipose tissues. OA presents diverse clinical …

Extracellular vesicles have gained wide momentum as potential therapeutics for
osteoarthritis, a highly prevalent chronic disease that still lacks an approved treatment. The …

Extracellular vesicles (EVs) are nanoparticles that include exosomes, microvesicles, and
apoptotic bodies; they interact with target cell surface receptors and transport contents …

Mesenchymal stem cells (MSCs) have been studied for decades as candidates for cellular
therapy, and their secretome, including secreted extracellular vesicles (EVs), has been …

Objectives Although subchondral bone marrow lesions (BMLs) and synovitis have been well
acknowledged as important sources of pain in knee osteoarthritis (KOA), it is unclear if …

MSCs are used for treatment of inflammatory conditions or for regenerative purposes. MSCs
are complete cells and allogenic transplantation is in principle possible, but mostly …

Background. Knee osteoarthritis (KOA) is a common degenerative joint disease. In this
study, we aimed to identify new biomarkers of KOA to improve the accuracy of diagnosis and …

Osteoarthritis (OA) is a degenerative joint disease, causing impaired mobility. There are
currently no effective therapies other than palliative treatment. Mesenchymal stromal cells …

The currently available osteoarthritis (OA) treatments offer symptoms' relief without disease-
modifying effects. Increasing evidence supports the role of human mesenchymal stem cells …

Background Skin photoaging is a condition caused by long‐term exposure to ultraviolet
irradiation, resulting in a variety of changes in the skin, such as capillary dilation, increased …